Evidence map›Paper›PMID 37950670›Full record

ArticleThe Journal of international medical research2023

Bin Wen, Limei Luo, Zhaoyang Zeng, Xiping Luo

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. NJournal of bioenergetics and biomembranes · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Bin WenThe First Clinical College of Jinan University, Guangzhou, Guangdong, P.R. China.ORCID 0000-0003-4731-6208
Limei LuoThe Second Clinical College, Guangzhou University of Chinese Medicine, Guangdong, P.R. China.
Zhaoyang ZengDepartment of Gynecology, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, P.R. China.
Xiping LuoThe First Clinical College of Jinan University, Guangzhou, Guangdong, P.R. China.ORCID 0000-0003-4303-3622
Jinan University · CNGuangzhou University of Chinese Medicine · CNTCM-Intigrated Cancer Center of Southern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study explored the mechanism of squamous cervical cancer (SCC) progression.

methodsReverse transcription-quantitative polymerase chain reaction and western blotting were used to evaluate the expression of myosin light chain 9 (

resultsThe mRNA and protein levels of

conclusionsMYL9 was upregulated in SCC, and it enhanced JAK2/STAT3 pathway activity and promoted metastasis and glycolysis in SCC.

Indexed as

Carcinoma, Squamous CellUterine Cervical NeoplasmsCell Line, TumorCell MovementCell ProliferationCervix UteriFemaleGene Expression Regulation, NeoplasticHumansMyosin Light ChainsPhosphorylationSTAT3 Transcription FactorMYL9 protein, humanMyosin Light ChainsSTAT3 Transcription Factoractivator of transcriptionaerobic glycolysisinvasionJanus kinase 2migrationMyosin light chain 9signal transducersquamous cervical cancer

Identifiers

PMID37950670
PMCPMC10640809
OpenAlexW4388592851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.